AI assistant
DEXCOM INC — Director's Dealing 2012
Mar 6, 2012
30198_dirs_2012-03-06_37be6aef-57c0-4cb2-82de-c45a9b1029ea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2012-03-05
Reporting Person: GREGG TERRANCE H (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-05 | Common Stock | S | 5000 | $10.31 | Disposed | 807076 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 30000 | Direct |
| Common Stock | 11461 | Indirect |
Footnotes
F1: On November 21, 2011, Mr. Gregg adopted a 10b5-1 Plan. Under the 10b5-1 Plan, Mr. Gregg will sell a limited number of shares to cover the tax liability that accrues upon monthly vesting of restricted stock units previously granted to Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Included in this number are 146,250 restricted stock units subject to vesting with respect to 1/36 of the units each month beginning one month following the grant date of March 12, 2010. Also included in this number are 182,813 restricted stock units subject to vesting with respect to 1/36 of the units each month beginning one month following the grant date of March 8, 2011.
F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.